All Stories

  1. Summary of Research: Collaboration Between Healthcare Professionals and People with Multiple Sclerosis to Develop Communication Tools to Improve the Standard of Multiple Sclerosis Care
  2. Measuring disability in multiple sclerosis: the WHODAS 2.0
  3. What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation
  4. Healthier living with MS: The key role of self-efficacy and emotion regulation
  5. Health and social care workers experiences of coping while working in the frontline during the COVID-19 pandemic: One year on
  6. Time to Rebaseline Cognitive Performance in People with Multiple Sclerosis?
  7. A Systematic Review and Meta-Analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) International Validations
  8. Measuring coping in multiple sclerosis: The Coping Index-MS
  9. What would improve MS clinic services for cognition? – A stakeholder panel and survey exploration
  10. The four self-efficacy trajectories among people with multiple sclerosis: Clinical associations and implications
  11. Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis
  12. Experiences of living with postural tachycardia syndrome
  13. Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
  14. Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing‐remitting multiple sclerosis
  15. Improving MS patients’ understanding of treatment risks and benefits in clinical consultations: A randomised crossover trial
  16. Polish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS battery): correlation of cognitive impairment with mood disorders and fatigue
  17. Cognitive Impairment Impacts Exercise Effects on Cognition in Multiple Sclerosis
  18. Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives
  19. State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis
  20. Identifying Progression in Multiple Sclerosis: New Perspectives
  21. A novel in-home digital treatment to improve processing speed in people with multiple sclerosis: A pilot study
  22. Editorial: Cognitive Disorders in Neuroimmunological Diseases
  23. Knowledge Is Power, but Is Ignorance Bliss? Optimising Conversations About Disease Progression in Multiple Sclerosis
  24. Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care
  25. Experiences of Low Mood in Young People With Cancer: A Qualitative Study
  26. Usability of Health Information Websites Designed for Adolescents: Systematic Review, Neurodevelopmental Model, and Design Brief
  27. Influence of different rehabilitative aerobic exercise programs on (anti-) inflammatory immune signalling, cognitive and functional capacity in persons with MS – study protocol of a randomized controlled trial
  28. Cognitive rehabilitation, self-management, psychotherapeutic and caregiver support interventions in progressive neurodegenerative conditions: A scoping review
  29. Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE study
  30. A Videogame-Based Digital Therapeutic to Improve Processing Speed in People with Multiple Sclerosis: A Feasibility Study
  31. Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier
  32. How does cognition relate to employment in multiple sclerosis? A systematic review
  33. Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in the Portuguese population with multiple sclerosis
  34. Learning ability correlates with brain atrophy and disability progression in RRMS
  35. Best Methods of Communicating Clinical Trial Data to Improve Understanding of Treatments for Patients with Multiple Sclerosis
  36. A Systematic Review and Meta-Analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS)
  37. The role of the cerebellum in multiple sclerosis—150 years after Charcot
  38. Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b
  39. The effect of self-assessed fatigue and subjective cognitive impairment on work capacity: The case of multiple sclerosis
  40. Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training
  41. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group
  42. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan
  43. Does including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation study
  44. High-intensity interval exercise improves cognitive performance and reduces matrix metalloproteinases-2 serum levels in persons with multiple sclerosis: A randomized controlled trial
  45. Influence of nationality on the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
  46. Multiple sclerosis patients' understanding and preferences for risks and benefits of disease-modifying drugs: A systematic review
  47. Functional training is a senseless strategy in MS cognitive rehabilitation: Strategy training is the only useful approach – NO
  48. Cognitive impairment in pediatric-onset multiple sclerosis is detected by the Brief International Cognitive Assessment for Multiple Sclerosis and computerized cognitive testing
  49. Interventions to support risk and benefit understanding of disease-modifying drugs in Multiple Sclerosis patients: A systematic review
  50. The contribution of short-term memory capacity to reading ability in adolescents with cochlear implants
  51. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis
  52. Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life
  53. A useful annual review of cognition in relapsing MS is beyond most neurologists – NO
  54. A Randomised Controlled Trial of Efficacy of Cognitive Rehabilitation in Multiple Sclerosis: A Cognitive, Behavioural, and MRI Study
  55. Cognitive assessment in MS
  56. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS)
  57. The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life
  58. Evaluating more naturalistic outcome measures
  59. Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group
  60. The brief international cognitive assessment for multiple sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population
  61. Triple dissociation of attention networks in stroke according to lesion location
  62. The mathematical abilities of children with cochlear implants
  63. Reports of Patients and Relatives from the CogniCIS Study about Cognition in Clinically Isolated Syndrome: What Are Our Patients Telling Us
  64. Treatment of cognitive impairment in multiple sclerosis: position paper
  65. Brief International Cognitive Assessment for MS (BICAMS): international standards for validation
  66. Survival in MS
  67. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
  68. Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
  69. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci
  70. Cognition in multiple sclerosis
  71. Verbal and Spatial Analogical Reasoning in Deaf and Hearing Children: The Role of Grammar and Vocabulary
  72. Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial
  73. Cross-sectional study assessing long-term safety of interferon- -1b for relapsing-remitting MS
  74. Constructing vignettes to investigate anger in multiple sclerosis
  75. Cognitive Impairment in Multiple Sclerosis - Recent Advances and Future Prospects
  76. Cerebellar Information Processing in Relapsing-Remitting Multiple Sclerosis (RRMS)
  77. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score
  78. The phenomenology of body image in men living with HIV
  79. Long-term follow-up of the original interferon-β1b trial in multiple sclerosis: Design and lessons from a 16-year observational study
  80. Executive Function and Language in Deaf Children
  81. Polymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosis
  82. Cerebellar contributions to working memory
  83. Future-directed thinking and depression in relapsing-remitting multiple sclerosis
  84. Exploration of the cognitive and behavioural consequences of paediatric cochlear implantation
  85. Exploration of the cognitive and behavioural consequences of paediatric cochlear implantation
  86. A longitudinal study of cognition in primary progressive multiple sclerosis
  87. The Cognition and Behaviour of Children with Cochlear Implants, Children with Hearing Aids and Their Hearing Peers: A Comparison
  88. Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach
  89. Does the Spelling Dyslexic Read by Recognizing Orally Spelled Words? An Investigation of a Letter-by-letter Reader
  90. Evidence-based measurement: Which disability scale for neurologic rehabilitation?
  91. A new test of memory for multiple sclerosis 1: Format development and stimuli design
  92. A new test of memory for multiple sclerosis I: Format development and stimuli design
  93. Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR
  94. Relation of impairment to everyday competence in visual disorientation syndrome: Evidence from a single case study
  95. Relation of impairment to everyday competence in visual disorientation syndrome: Evidence from a single case study
  96. Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR
  97. Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis
  98. The Role of the Left Hemisphere in Verbal and Spatial Reasoning Tasks
  99. Cognitive function in primary progressive and transitional progressive multiple sclerosis: A controlled study with MRI correlates
  100. Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome
  101. Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome
  102. Inpatient rehabilitation in multiple sclerosis: Do the benefits carry over into the community?
  103. Discrepancy poor verbal skills in poor readers: A failure of learning or ability?
  104. The impact of inpatient rehabilitation on progressive multiple sclerosis
  105. Resolution of Left Hemisphere Cognitive Dysfunction in Multiple Sclerosis with Magnetic Resonance Correlates: A Case Report
  106. Rehabilitation of incomplete spinal cord pathology: Factors affecting prognosis and outcome
  107. Health-Related Quality of Life in People with Multiple Sclerosis Undergoing Inpatient Rehabilitation
  108. Spelling dyslexia: a deficit of the visual word-form.
  109. Verbal and Spatial Reasoning Test
  110. Benefit and risk information for medications in multiple sclerosis
  111. Cognitive rehabilitation in multiple sclerosis